The UK Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have opened a call for evidence to assess the impact of resources produced under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and is scheduled to close on 26 February 2027.
The agencies are seeking views from developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers, regulators, people with lived experience of mental health conditions, carers and members of the public.
According to MHRA and NICE, the survey is part of the programme’s Phase 1 evaluation. It aims to establish how the resources have been received and used across the sector. The agencies are particularly interested in whether the materials have affected users’ knowledge, confidence, decision-making and professional practice.
The resources were created to support the safe development, regulation, evaluation and adoption of digital mental health technologies, including mental health apps and other digital tools. Survey findings will help determine whether Phase 1 outputs met their intended objectives and will inform the future direction of Phase 2.
MHRA and NICE encourage stakeholders to respond whether they have used the resources extensively, minimally or not at all. The agencies say the feedback will help identify strengths, point to areas for improvement and shape future work intended to improve the safety and effectiveness of digital mental health technologies.